MedTrace Logo

Power Training Progression Methods

NCT07378826 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-02-02

No results posted yet for this study

Summary

This study will investigate the impact of two unique progression models for power training in a sample of healthy older adults. The objective is to identify the most practical methodology for implementing power training, which is considered a critical marker of functional capacity in older populations.

Conditions

  • Activity, Motor

Interventions

BEHAVIORAL

RPE-Based Power Training

The RPE system will be based on movement speed with an unloaded condition producing maximal speed (RPE=10) and a 1RM producing minimal speed (RPE = 1). If RPE is above 5, loads will be increased by 5% for upper body exercises and 2.5% for lower body exercises. If the RPE = between 4 and 5 the load will remain unchanged. If RPE falls below 4, loads will be lowered using the same percentages.

BEHAVIORAL

Power Plateau-Based Power Training

Following two training sessions, the average power for each exercise will be calculated. When average power increases by a minimum of 5% from session one to session two, the load will remain unchanged to continue to reap power improvements. When the average power does not increase by at least 5% from session one to two, the load will be increased by the same protocol described above. Loads will only decrease when subjects cannot complete all repetitions with adequate form.

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Joseph F. Signorile, PhD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-30
Primary Completion
2027-05-30
Completion
2027-05-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07378826 on ClinicalTrials.gov